Joel Becker is a transformational healthcare and medical device executive with deep M&A, strategy, and operational credentials. He currently serves as CEO of NeuroPace (NASDAQ: NPCE), where he has overseen a 300% increase in share price through visionary growth planning and executive team upgrades.
Joel strengthens NDFC's healthcare acquisition strategy through:
- •Deep expertise in scaling medtech and healthcare service businesses
- •Proven leadership in turnaround execution and strategic repositioning
- •Extensive IPO and public market experience to guide exit pathways
With senior roles at St. Jude Medical, Integer Holdings, and venture-backed startups, Joel delivers both scale and agility — vital ingredients in NDFC's ability to grow acquired healthcare companies into category leaders.
Joel is a mission-driven leader with more than twenty-five years of experience in successfully building, growing and leading medical technology companies. His extensive functional expertise and experience in General Management, Sales, Marketing, M&A, and Operations is a true value for our portfolio businesses.
CEO of NeuroPace (NASDAQ: NPCE); oversaw a 300% increase in share price Senior roles at St. Jude Medical and Integer Holdings 25+ years in medical technology including general management, sales, marketing, M&A, and operations Expertise in healthcare company turnarounds, strategic repositioning, and IPO pathways Advises NDFC on healthcare and medtech acquisitions and post-acquisition growth strategy